FindTrial
Sign In

Effect of sodium-glucose cotransporter 2 inhibitor on the prognosis of patients with acute ST-segment elevation myocardial infarction

Effect of sodium-glucose cotransporter 2 inhibitor on the prognosis of patients with acute ST-segment elevation myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054546
Enrollment
Unknown
Registered
2021-12-19
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-elevated acute myocardial infarction

Interventions

SGLT2i group:None
non-SGLT2i group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male or female aged >=18 years; 2. Newly diagnosed acute myocardial infarction; 3. Have good compliance; 4. Obtain written informed consent.

Exclusion criteria

Exclusion criteria: Expected lifetime < 6 month.

Design outcomes

Primary

MeasureTime frame
height;weight;blood pressure;heart rate;left ventricular ejection fraction;left ventricular end-diastolic diameter;left ventricular shortening rate;left atrial diameter;right atrial diameter;Right Indoor Diameter;Glycated hemoglobin;total cholesterol;triglycerides;high-density lipoprotein cholesterol;low density lipoprotein cholesterol;alanine aminotransferase;aspartate aminotransferase;Creatinine;urea nitrogen;uric acid;hemoglobin;platelets;leukocyte;—

Countries

China

Contacts

Public ContactYang Liu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

liuyanghust@hust.edu.cn+86 15902729363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026